20 May 2013
Keywords: cerepro, ph, iii, trial, gets, dsmb, go
Article | 15 January 2007
UK-based health care group Ark Therapeutics says that the observed side effect profile in a Phase III trial of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 2007
22 January 2007
© 2013 thepharmaletter.com